RAV-18

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRAV-18
Drug Alias NameKID-24 antibody (Raven)RAV-18
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 9 modulators
TargetsDisintegrin and metalloproteinase domain-containing protein 9
Therapy Area/IndicationsLung NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRaven Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRaven Biotechnologies Inc
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A